Stocks and Investing
Stocks and Investing
Wed, May 15, 2024
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
Tue, May 14, 2024
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
David Nierengarten Reiterated (STRO) at Buy and Held Target at $8 on, May 14th, 2024
David Nierengarten of Wedbush, Reiterated "Sutro Biopharma, Inc." (STRO) at Buy and Held Target at $8 on, May 14th, 2024.
David has made no other calls on STRO in the last 4 months.
There are 5 other peers that have a rating on STRO. Out of the 5 peers that are also analyzing STRO, 0 agree with David's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with David
- Tazeen Ahmad of "B of A Securities" Initiated at Strong Buy and Held Target at $12 on, Wednesday, May 8th, 2024
- Asthika Goonewardene of "Truist Securities" Maintained at Strong Buy with Decreased Target to $18 on, Wednesday, April 3rd, 2024
- Edward Tenthoff of "Piper Sandler" Reiterated at Buy with Decreased Target to $11 on, Wednesday, April 3rd, 2024
- Jay Olson of "Oppenheimer" Maintained at Buy and Held Target at $10 on, Wednesday, April 3rd, 2024
- Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $17 on, Wednesday, April 3rd, 2024
Contributing Sources